Biology subjects

Gallego, S.

Publications and source records attributed to Gallego, S..

8 recordsLinked to original sources

bioRxiv2026

Colorful connections: pigment-based plumage and breeding condition are associated with gut microbiome variation in the Common Yellowthroat

Carotenoid- and melanin-based plumage coloration traits are key signals in avian communication and sexual selection as they are often thought to provide "honest" information about individual condition and fitness. These traits arise through distinct but interconnected physiological and genetic pathways. Recent work suggests that there may be a link between host-associated gut microbiota and the functional pathways leading to pigment-based plumage coloration, but this remains largely unexplored in wild populations. To address this gap, we tested whether variation in plumage coloration, as well as breeding condition, is associated with gut microbiome variation in wild populations of male Common Yellowthroats (Parulidae: Geothlypis trichas). We quantified multiple plumage coloration traits and characterized gut microbiome bacterial diversity using 16S rRNA metabarcoding. Through a comprehensive modeling framework, we found that individuals with brighter, more orange-tinted breast feathers and smaller cloacal protuberances (a proxy for breeding condition) exhibited higher gut microbiome diversity. At the taxonomic level, Methylobacterium-Methylorubrum, a carotenoid-producing bacteria, showed strong associations with multiple plumage traits, including mask area, breast feather hue, and saturation. Our results demonstrate that gut microbiome diversity is associated with variation in carotenoid-based coloration traits and breeding condition in Common Yellowthroats. More broadly, these results highlight the potential for host-microbiome interactions to shape phenotypic variation through physiological pathways in wild animal populations.

ecology↗

bioRxiv2026

Antimicrobial resistant bacteria in wastewater-irrigated Mexican soils and transfer of resistant bacteria from irrigated soils to cilantro plants

Agricultural fields in the Mezquital Valley, Mexico, were irrigated with untreated wastewater over several decades. Following the construction of a wastewater treatment plant (WWTP) in Atotonilco de Tula, WWTP effluent is used for irrigation. To evaluate the effects of changed irrigation, a soil incubation experiment was performed. Soils of the Mezquital Valley long-term irrigated with untreated wastewater were irrigated with WWTP influent or effluent, both unspiked and spiked with antibiotics and biocidal compounds and incubated four weeks. We investigated the effects of shifted irrigation on the abundance of cultivable total heterotrophic and resistant bacteria (RB). Additionally, RB were cultivated from Coriandrum sativum (cilantro) sown in soil of the incubation experiment. While wastewater treatment significantly reduced the bacterial abundance in effluent, spiking increased RB abundance in both wastewater types including ciprofloxacin (CIP) RB. Before wastewater addition, all soils contained cultivable RB. Irrigation increased the relative abundance of RB cultivated on Mueller Hinton (MH) agar in Leptosols and Phaeozems, compared to soils prior to wastewater addition irrespective of the water type, but not in Vertisols, suggesting the soil type rather than water qualities influenced the RB abundance. Diverse CIP RB were cultivated including strains of 14 genera of three phyla. Among those, Achromobacter spp. strains related to potentially pathogenic A. spanius originating from soil were abundant in both leaves and roots of cilantro. Our results showed that the implementation of wastewater treatment does not reduce the abundance of cultivable RB in Mezquital Valley soils and cilantro plants. Health risk associated monitoring should include long-term persistent RB colonizing plants cultivated in wastewater irrigated soils.

microbiology↗

bioRxiv2026

Hidden palette: Culturing the sauropsid gut microbiome reveals a high prevalence and diversity of bacteria that undergo carotenoid biosynthesis

Pigments play essential roles in communication, sexual signaling, and ecological adaptation in taxa across the tree of life and are especially important for animals, which often rely on carotenoid pigments for their coloration. One potentially important yet largely overlooked source of pigments is host-associated microbes. Microbial carotenoids may influence host coloration or other fitness-related traits, but the extent to which they occur or vary across associations with host species remains largely unknown. To begin to address this gap, we used culture-based techniques to isolate gut-associated bacteria from multiple wild sauropsid species. We cultured 157 morphologically distinct bacterial isolates from 25 individuals representing eight host species; 17% of isolates were yellow- or orange-pigmented, and 40% of isolates exhibited absorbance spectra consistent with the presence of carotenoids. Sequencing of the 16S rRNA gene revealed that isolates spanned four phyla and 35 genera. Isolates that were consistent with the presence of carotenoids were found across all four phyla, with Pantoea being the most frequently represented carotenoid-associated genus. These results demonstrate that carotenoid-capable bacteria are both taxonomically diverse and prevalent in the gut microbiomes of wild sauropsids. More broadly, our findings provide insight into a hidden dimension of host-microbe interactions and their potential function.

microbiology↗

bioRxiv2024

Combined inhibition of MDM2 and PARP lead to a synergistic anti-tumoral response in p53 wild-type rhabdomyosarcoma models

Targeting MDM2-p53 interaction to enhance p53 activity represents a promising antitumoral strategy for p53 wild-type pediatric tumors, including soft-tissue sarcomas. However, results from early-phase clinical trials in hematological and solid cancers have shown limited efficacy of MDM2 inhibitors, underscoring the necessity to explore more effective combinations with other agents. In this study, we provide results from a 22-drug combination screening demonstrating the therapeutic potential of combining siremadlin (MDM2 inhibitor) and olaparib (PARP inhibitor) for treating p53 wild-type rhabdomyosarcoma (p53 WT RMS). Cell survival, cell death, and apoptosis analysis revealed synergistic effects of combining siremadlin plus olaparib in vitro. The combination of both drugs led to a significant increase in p53 activity, as evidenced by p53 accumulation and K382 acetylation, along with an increased expression of bona fide p53 targets. Furthermore, treatment with both drugs resulted in significant reduction of tumor growth and increased mice overall survival when compared to single treatments and control in cell line-derived orthotopic xenograft models. Overall, our study demonstrates, for the first time, the synergistic effect of combining siremadlin plus olaparib in inhibiting p53 WT RMS tumor growth in vitro and in vivo. Our findings support the potential to study the combination of both drugs in clinical trials and warrants further investigation in other tumors with similar molecular features.

cancer biology↗

bioRxiv2023

TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma

BackgroundRhabdomyosarcoma (RMS), such as other childhood tumors, has witnessed treatment advancements in recent years. However, high-risk patients continue to face poor survival rates, often attributed to the presence of the PAX3/7-FOXO1 fusion proteins, which has been associated with metastasis and treatment resistance. Despite efforts to directly target these chimeric proteins, clinical success remains elusive. In this study, the main aim was to address this challenge by investigating regulators of FOXO1. Specifically, we focused on TRIB3, a potential regulator of the fusion protein in RMS. MethodsTRIB3 expression was examined through the analysis of patient datasets, including gene expression profiling and gene set enrichment analyses. In cell lines, the DepMap dataset for RMS was utilized alongside Western blot analysis to assess TRIB3 expression. The functional significance of TRIB3 in RMS was assessed through constitutive and inducible shRNA-mediated knockdowns. Subsequent in vitro and in vivo analyses, including orthotopic tumor models in immune-compromised mice, were conducted to delineate the role and underlying molecular mechanisms exerted by TRIB3 in RMS ResultsOur findings revealed a prominent TRIB3 expression in RMS tumors, highlighting its correlation with several clinical features. By conducting TRIB3 genetic inhibition experiments, we observed an impairment on cell proliferation. Notably, the knockdown of TRIB3 led to a decrease in PAX3-FOXO1 and its target genes at protein level, accompanied by a reduction in the activity of the Akt signaling pathway. Furthermore, TRIB3 influenced posttranslational modifications, such as phosphorylation together with proteasomal degradation of PAX3-FOXO1 protein. Additionally, inducible silencing of TRIB3 significantly delayed tumor growth and improved overall survival in vivo. ConclusionsBased on our comprehensive analysis, we propose that TRIB3 holds therapeutic potential for treating the most aggressive subtype of RMS. The findings herein reported contribute to our understanding of the underlying molecular mechanisms driving RMS progression and provide novel insights into the potential use of TRIB3 as a therapeutic intervention for high-risk RMS patients.

cancer biology↗

bioRxiv2022

Analysis of cancer genomic amplifications identifies druggable collateral dependencies within the amplicon

The identification of novel therapeutic targets for specific cancer molecular subtypes is crucial for the development of precision oncology. In the last years, CRISPR/Cas9 screens have accelerated the discovery and validation of new targets associated with different tumor types, mutations or fusions. However, there are still many cancer vulnerabilities associated with specific molecular features that remain to be explored. Here we used data from CRISPR/Cas9 screens in 954 cancer cell lines to identify gene dependencies associated with 16 common cancer genomic amplifications. We found that high-copy number genomic amplifications generate multiple collateral dependencies within the amplified region in 94% of cases. Further, to prioritize candidate targets for each chromosomal region amplified, we integrated gene dependency parameters with both druggability data and subcellular location. Finally, analysis of the relationship between gene expression and gene dependency leads to the identification of genes, the expression of which may constitute predictive biomarkers of dependency.

cancer biology↗

bioRxiv2022

Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

BackgroundEpigenetic programming during development is essential for determining cell lineages, and alterations in this programming contribute to the initiation of embryonal tumour development. In neuroblastoma, neural crest progenitors block their course of natural differentiation into sympathoadrenergic cells, leading to the development of aggressive and metastatic paediatric cancer. Research of the epigenetic regulators responsible for oncogenic epigenomic networks is crucial for developing new epigenetic-based therapies against these tumours. Mammalian switch/sucrose non-fermenting (mSWI/SNF) ATP-dependent chromatin remodelling complexes act genome-wide translating epigenetic signals into open chromatin states. The present study aimed to understand the contribution of mSWI/SNF to the oncogenic epigenomes of neuroblastoma and its potential as a therapeutic target. MethodsFunctional characterisation of the mSWI/SNF complexes was performed in neuroblastoma cells using proteomic approaches, loss-of-function experiments, transcriptome and chromatin accessibility analyses, and in vitro and in vivo assays. ResultsNeuroblastoma cells contain three main mSWI/SNF subtypes, but only BRG1-associated factor (BAF) complex disruption through silencing of its key structural subunits, ARID1A and ARID1B, impairs cell proliferation by promoting cell cycle blockade. Genome-wide chromatin remodelling and transcriptomic analyses revealed that BAF disruption results in the epigenetic repression of an extensive invasiveness-related expression program involving integrins, cadherins, and key mesenchymal regulators, thereby reducing adhesion to the extracellular matrix and the subsequent invasion in vitro and drastically inhibiting the initiation and growth of neuroblastoma metastasis in vivo. ConclusionsWe report a novel ATPase-independent role for the BAF complex in maintaining an epigenomic program that allows neuroblastoma invasiveness and metastasis, urging for the development of new BAF pharmacological structural disruptors for therapeutic exploitation in metastatic neuroblastoma.

cancer biology↗

bioRxiv2020

Lipid metabolic stress in development defines which genetically-susceptible DYT-TOR1A mice develop disease

There has been enormous progress defining the genetic landscape of disease. However, genotypes rarely fully predict neurological phenotypes, and we rarely understand why. TOR1A +/{Delta}gag that causes dystonia with ~30% penetrance is a classic case. Here we show, in inbred mice, that +/{Delta}gag affects embryonic brain lipid metabolism with sex-skewed reduced penetrance. Penetrance is affected by environmental context, including maternal diet. The lipid metabolic defect resolves during post-natal development. Nevertheless, we discover dystonia-like symptoms in ~30% of juvenile female Tor1a+/{Delta}gag mice, and prevent these symptoms by genetically suppressing abnormal lipid metabolism. We conclude that Tor1a+/{Delta}gag embryos poorly buffer metabolic stress in utero, resulting in a period of abnormal metabolism that hardwires the brain for dystonia in later life. The data show unexpected and profound impacts of sex, and thus highlight the importance of examining male and female animal models of disease. Significance StatementThe genetic landscape of neurological disease is relatively well mapped. However, we typically cannot explain why some mutations only cause disease in a subset of individuals. A classic case is DYT-TOR1A dystonia that only develops in 30% of TOR1A+/{Delta}gag carriers. We now find that ~30% of inbred female Tor1a+/{Delta}gag mice develop abnormal brain lipid metabolism as embryos, while males are spared. The percentage is affected by maternal diet. Further, this period of abnormal lipid metabolism causes dystonia-like symptoms in juvenile mice. These data show how an environmentally-sensitive event of development defines which genetically-susceptible individuals develop disease in later life. They also highlight the importance of examining male and female animal models of disease.

neuroscience↗